Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,361,296
-
Total 13F shares
-
13,758,120
-
Share change
-
+13,643,120
-
Total reported value
-
$199,086,000
-
Price per share
-
$14.50
-
Number of holders
-
31
-
Value change
-
+$197,418,000
-
Number of buys
-
30
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q1 2016
As of 31 Mar 2016 Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,758,120 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Novo A/S, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, Rock Springs Capital Management LP, SCOPIA CAPITAL MANAGEMENT LP, CREDIT SUISSE AG/, Alyeska Investment Group, L.P., and Allianz Asset Management AG.
This table shows 31 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.